- Report
- November 2023
- 175 Pages
Global
From €4721EUR$5,000USD£4,050GBP
- Report
- March 2022
- 300 Pages
Global
From €4721EUR$5,000USD£4,050GBP
- Report
- March 2024
- 254 Pages
Global
From €2313EUR$2,450USD£1,984GBP
- Report
- January 2024
- 150 Pages
Global
From €4579EUR$4,850USD£3,928GBP
- Report
- November 2023
- 150 Pages
Global
From €4579EUR$4,850USD£3,928GBP
- Report
- September 2021
- 40 Pages
China
From €2455EUR$2,600USD£2,106GBP
- Report
- July 2021
- 50 Pages
China
From €2455EUR$2,600USD£2,106GBP
From €2455EUR$2,600USD£2,106GBP
- Report
- June 2021
- 50 Pages
China
From €2455EUR$2,600USD£2,106GBP
- Report
- April 2021
China
From €2455EUR$2,600USD£2,106GBP
- Report
- April 2021
- 50 Pages
China
From €2455EUR$2,600USD£2,106GBP
- Report
- September 2020
- 40 Pages
China
From €2266EUR$2,400USD£1,944GBP
- Report
- September 2019
- 30 Pages
China
From €2077EUR$2,200USD£1,782GBP
- Report
- July 2018
- 30 Pages
China
From €2077EUR$2,200USD£1,782GBP
- Report
- November 2023
- 245 Pages
Global
From €4202EUR$4,450USD£3,604GBP
- Report
- November 2023
- 420 Pages
Global
From €4202EUR$4,450USD£3,604GBP
- Report
- December 2021
- 191 Pages
Global
From €4202EUR$4,450USD£3,604GBP
- Report
- October 2021
- 157 Pages
Global
From €4202EUR$4,450USD£3,604GBP
- Report
- May 2023
- 118 Pages
Global
From €4249EUR$4,500USD£3,645GBP
- Report
- August 2022
- 115 Pages
Global
From €4249EUR$4,500USD£3,645GBP

The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders.
The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more